To Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Calcipotriene 0.005%, Applied Under Maximal Use Conditions in 12-16 Year Olds With Plaque Psoriasis
This study is currently recruiting participants.
Verified May 2013 by GlaxoSmithKline
Study NCT01563068
Information provided by GlaxoSmithKline
First Received on March 15, 2012.
Last Updated on June 6, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
